Scientists Create NICE Solution to Pneumonia Vaccine Testing Problems

Oct 20, 2009
Pneumococcus colonies (bottom) ordinarily must be counted manually to determine whether pneumonia vaccine is effective on a patient, but freely available NICE software (top) developed at NIST will help automate the process, potentially saving many lives in the world’s developing regions. Credit: NIST

(PhysOrg.com) -- Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology, where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB).

Pneumonia is the world's leading cause of death in children under five years of age and poses a serious risk to elderly adults. The leading cause of worldwide is the pneumococcus bacterium, which also causes meningitis, sepsis and other complications. Pneumococcus has more than 90 strains that vary by geographic region and change over time. Consequently, ongoing testing is necessary to monitor existing vaccines and advance new ones.

Pneumococcus colonies (bottom) ordinarily must be counted manually to determine whether pneumonia vaccine is effective on a patient, but freely available NICE software (top) developed at NIST will help automate the process, potentially saving many lives in the world’s developing regions. Credit: NIST

One novel, high-throughput testing method involves culturing the bacteria along with a vaccinated person's blood serum and human . If the vaccine is effective, the white cells kill the pneumococci and very few of the bacteria survive. Scientists can determine the vaccine's effectiveness by counting the number of surviving pneumococcus colonies, so rapid, accurate and standardized counting of these colonies is critical to this testing method.

At present, the most commonly used counting process is manual counting, which is both time-consuming and exhausting. "Automated counting devices do exist, but they require customized image acquisition methods, are very expensive and are not accessible in impoverished or developing regions of the world. These limiting factors can mean the difference between life and death," says NIST biophysicist Jeeseong Hwang. "So we created software that can be tweaked to work on any common imaging device."

The open-source software, called NIST's Integrated Colony Enumerator (NICE), takes a digital image that has been loaded into a computer and counts colonies grown from single pneumococcal cells. The Microsoft Windows-based software works on images from both digital cameras and flatbed scanners, which are widely available and inexpensive, costing less than $1,000 each. "NICE obtains results that agree well with manual counting, the current gold standard," says Matthew Clarke, who developed the program algorithm and code in Hwang's group. "There's a mean difference of only 3 percent between the two methods."

The project grew from informal talks between NIST and UAB, where researcher Moon H. Nahm developed the testing method. Nahm has been working with vaccine testing methods to support projects by the National Institutes of Health and PATH, a nonprofit organization dedicated to improving health in poor communities around the world. As NIST scientists have been developing ways to standardize counting particles, PATH provided funding and worked with NIST. After 18 months of effort, NICE is now ready.

"We have already identified several clinics in Asia, where we feel many of the potential users are," Hwang says. "We're hoping to get feedback from them so we can improve the software in the future."

*More information: The two software files required to run NICE, along with additional images demonstrating their use, can be downloaded at ftp://ftp.nist.gov/pub/physics/mlclarke/NICE . The files, written in the language MATLAB R2008B, are MCRInstaller.exe (MATLAB compiler engine 7.9) and NICE_B1r.exe (launches NICE).

Provided by National Institute of Standards and Technology (news : web)

Explore further: Researchers treat heart attacks with new gene therapy based on telomerase enzyme

add to favorites email to friend print save as pdf

Related Stories

New insights could lead to a better pneumococcal vaccine

Sep 22, 2008

Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at ...

Researchers pave the way for anthrax spore standards

Apr 15, 2008

Researchers from the National Institute of Standards and Technology (NIST) and the U.S. Army Dugway (Utah) Proving Ground have developed reliable methods based on DNA analysis to assess the concentration and ...

New NIST reference material reinforces fragile-x screens

Feb 25, 2005

A new Standard Reference Material from the National Institute of Standards and Technology (NIST) will help clinical genetics labs improve the accuracy of their diagnostic tests for the most common cause of hereditary mental ...

Recommended for you

Stem cells faulty in Duchenne muscular dystrophy

23 hours ago

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.